Intraocular pressure elevations with loteprednol etabonate: A retrospective chart review

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 3, 2011, Pages 305-308

  Rajpal, Rajesh K ^a   Digby, Donald ^b   D'Aversa, Gerard ^c   Mah, Francis ^d   Hollander, David A ^e   Conway, Taryn ^e  

^a SeeClearly Vision   (United States)

^b Digby Eye Associates   (United States)

^c OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOTEPREDNOL ETABONATE; LOTEPREDNOL ETABONATE PLUS TOBRAMYCIN;

ADULT; ALLERGIC CONJUNCTIVITIS; BLEPHARITIS; CLINICAL ARTICLE; DISEASE SEVERITY; DRY EYE; EPISCLERITIS; FEMALE; HERPES SIMPLEX KERATITIS; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; IRITIS; KERATITIS; KERATOCONJUNCTIVITIS; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; OPEN ANGLE GLAUCOMA; REVIEW; SCLERITIS; UVEITIS;

ADULT; AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; DRUG COMBINATIONS; DRUG MONITORING; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MALE; MEDICAL RECORDS; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOBRAMYCIN;

EID: 79958776496     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2010.0182     Document Type: Review

References (12)

1. McGhee, C.N., Dean, S., and Danesh-Meyer, H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 25:33-55, 2002. (Pubitemid 34208330)
2. Carnahan, M.C., and Goldstein, D.A. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr. Opin. Ophthalmol. 11:478-483, 2000.
3. Kersey, J.P., and Broadway, D.C. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond). 20:407-416, 2006.
4. Pavesio, C.E., and Decory, H.H. Treatment of ocular inflammatory conditions with loteprednol etabonate. Br. J. Ophthalmol. 92:455-459, 2008. (Pubitemid 351497967)
5. Comstock, T.L., and Holland, E.J. Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens. Expert Opin. Pharmacother. 11:843-852, 2010.
6. Holland, E.J., Bartlett, J.D., Paterno, M.R., Usner, D.W., and Comstock, T.L. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Cornea 27:50-55, 2008.
7. Armaly, M.F., and Becker, B. Intraocular pressure response to topical corticosteroids. Fed. Proc. 24:1274-1278, 1965.
8. Bartlett, J.D., Horwitz, B., Laibovitz, R., and Howes, J.F. Intraocular pressure response to loteprednol etabonate in known steroid responders. J. Ocul. Pharmacol. 9:157-165, 1993. (Pubitemid 23187584)
9. Novack, G.D., Howes, J., Crockett, R.S., and Sherwood, M.B. Change in intraocular pressure during long-term use of loteprednol etabonate. J. Glaucoma 7:266-269, 1998. (Pubitemid 29149820)
10. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul. Surf. 5:75-92, 2007.
11. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop. Ocul. Surf. 5:163-178, 2007.
12. Behrens, A., Doyle, J.J., Stern, L., et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900-907, 2006. (Pubitemid 44763848)